BioVaxys Technology Corp.
BioVaxys Technology Corp.
CSE Index:
Currency:
BioVaxys Technology Corp. is a clinical-stage immunotherapeutics company developing vaccine platforms for SARS-CoV-2 and various cancers.
BioVaxys Technology Corp. (BIOV)
SEDAR Information
Company Info
Address
503 - 905 West Pender Street
Vancouver, BC V6C 1L6
CanadaPhone
646-452-7000Email
[email protected]Website
https://biovaxys.com/Listing date
Wednesday, November 21, 2018Transfer Agent
Odyssey Trust CompanyAuditor
Dale Matheson Carr-Hilton Labonte LLPCapitalization
Issued & Outstanding:
105,530,845Reserved for Issuance:
34,818,574Company Officers
James Passin, CEO
Kenneth Kovan, COO & President
Craig Loverock, CFO
Bulletins
05/10/2020
2020-1008 – Fundamental Change - Lions Bay Mining Corp./BioVaxys Technology Corp.
le 5 octobre/October 2020
BioVaxys Technology Corp., the issuer resulting from a Fundamental Change of Lions Bay Mining Corp. (LBM), has been approved for listing.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
BioVaxys Technology Corp. is a clinical-stage immunotherapeutics company developing vaccine platforms for SARS-CoV-2 and various cancers.
____________________________
Advertisement
Publicité
